This website is designed for research purposes only. The algorithm has not been validated for clinical use.

This site is linked to the study: Bayer et al., Network-based clustering unveils interconnected landscapes of genomic and clinical features across myeloid malignancies, 2023.

The platform was developed using a dataset from a cohort of 1,323 patients, which consisted of 543 patients with AML, 118 with CMML, 492 with MDS, and 170 with MPN.

By accessing this site, you acknowledge the limitations of this research website.